relapsed or refractory acute myeloid leukemia
GPTKB entity
Statements (45)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:CYAD-101
gptkb:gemtuzumab_ozogamicin |
| gptkbp:affects |
bone marrow
|
| gptkbp:associated_with |
high mortality rate
|
| gptkbp:can_lead_to |
gptkb:healthcare_organization
complications |
| gptkbp:caused_by |
genetic abnormalities
|
| gptkbp:clinical_trial |
ongoing research
|
| https://www.w3.org/2000/01/rdf-schema#label |
relapsed or refractory acute myeloid leukemia
|
| gptkbp:is_a |
hematologic malignancy
|
| gptkbp:is_associated_with |
secondary malignancies
|
| gptkbp:is_characterized_by |
resistance to treatment
abnormal myeloid cells |
| gptkbp:is_considered |
a challenging condition
|
| gptkbp:is_often_used_in |
gptkb:Person
adults men |
| gptkbp:is_part_of |
hematology
|
| gptkbp:is_studied_in |
clinical research
|
| gptkbp:is_used_for |
gptkb:fandom
thrombocytopenia leukopenia |
| gptkbp:occurs_in |
initial treatment failure
|
| gptkbp:requires |
palliative care
intensive treatment |
| gptkbp:risk_factor |
genetic mutations
previous chemotherapy older age |
| gptkbp:social_responsibility |
blood tests
cytogenetic analysis poor prognosis bone marrow biopsy |
| gptkbp:symptoms |
fatigue
weight loss fever easy bruising |
| gptkbp:treatment |
gptkb:vaccine
chemotherapy targeted therapy stem cell transplant novel agents variable response to therapy |
| gptkbp:type_of |
gptkb:acute_leukemia
|